Search results for: 'video diagnostics'

The pandemic was a great equalizer with everyone being remote. Mass adoption of video meetings, chat, virtual whiteboarding, and group messaging kept everyone productive and fully connected. Everyone had the same presence and an equal voice during video meetings. As people return to the office, there is a growing challenge of keeping the same level...

Frost & Sullivan's on-going research into the video conferencing services market identified education as one of the key vertical industries for growth of video conferencing infrastructure and endpoints. Virtual learning is on the technology road-maps of most educational institutions and is a key enabler of highly popular distance learning courses. ...

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, digital health and diagnostics industry. The issue includes advanced medical devices such as artificial intelligence-powered linear accelerator (Linac), left ventricular assist device, nex...

Frost & Sullivan’s Trend Opportunity Profiles cover specific opportunities emerging from future trend evolutions and are designed to help clients discover and prioritize the most consequential mid-to-long term trends transforming their business growth environment. To create each profile, Frost & Sullivan analyzes the trend opportunity across key in...

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. ...

08 Nov 2024  |  Global  |  Market Research

Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030

Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development

Infographics

×

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. ...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...